This inventor holds 5 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 10 EPO patents. Top assignee: Axiogenesis Ag. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2018
Title: The Innovative Mind of Heribert Bohlen
Introduction
Heribert Bohlen is a prominent inventor based in Köln, Germany. With a strong background in biotechnology and stem cell research, he holds five patents that significantly contribute to the fields of drug discovery and functional tissue assays. His innovative work continues to push the boundaries of research and development in medical technology.
Latest Patents
Among his recent contributions, Bohlen's patents include a non-invasive, in vitro functional tissue assay system. This system introduces substrate-integrated multifunctional microelectrode arrays that leverage stem cell technology, allowing researchers to examine both normal and pathogenic characteristics of tissues. Another notable patent focuses on an assay for drug discovery. This patent describes a system designed to evaluate the therapeutic or toxic effects of potential drugs by assessing their activity in cells differentiated from stem cells. These cells are engineered to mimic the phenotypes of diseases targeted for treatment, further streamlining the drug development process.
Career Highlights
Bohlen's career is marked by his continuous commitment to advancing scientific knowledge. He has dedicated himself to developing innovative technologies that address some of the most pressing challenges in medicine today. His expertise in functional assays and stem cell technologies has led to significant advancements, paving the way for more effective treatments and personalized medicine.
Collaborations
Heribert Bohlen collaborates with talented professionals such as Andreas Ehlich and Silke Schwengberg at Axiogenesis AG. Together, they form a dynamic team that drives innovation and research excellence in the biotechnology sector. Their combined efforts enhance the development of novel systems that benefit both the scientific community and society as a whole.
Conclusion
Heribert Bohlen's contributions to innovation and invention in biomedical technologies underscore the importance of research in improving patient outcomes. His patents reflect a commitment to advancing science and a passion for exploring the capabilities of stem cell technology. As he continues to work with Axiogenesis AG, Bohlen will undoubtedly inspire future breakthroughs in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile